• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

俄罗斯联邦伊万诺沃州结核病控制政策的成本效益分析。伊万诺沃结核病项目研究小组

Cost-effectiveness analysis of tuberculosis control policies in Ivanovo Oblast, Russian Federation. Ivanovo Tuberculosis Project Study Group.

作者信息

Migliori G B, Khomenko A G, Punga V V, Ambrosetti M, Danilova I, Ribka L N, Grzemska M, Sawert H, Raviglione M C

机构信息

Fondazione Salvatore Maugeri, Care and Research Institute, Tradate, Italy.

出版信息

Bull World Health Organ. 1998;76(5):475-83.

PMID:9868838
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2305776/
Abstract

Many of the current tuberculosis control programmes in the Russian Federation are based on costly strategies which are underfunded and use long, individualized treatment regimens. This article compares, using a cost-effectiveness analysis, the new WHO strategy implemented in the Ivanovo Oblast (case-finding among symptomatic patients (SCF) and shorter regimens) and the old strategy (active screening of the asymptomatic population (ACF) and longer regimens). The cost per case cured was calculated at different levels of cure rate (45-95%) using three scenarios to describe the new WHO strategy (use of WHO-recommended regimens and three options at increasing rates of admission) and a fourth scenario to describe the old strategy (all patients admitted for the whole treatment and longer regimens). The cost per case detected was determined by calculating the following: yield of the new and old strategy (number of examinations necessary to diagnose one case); cost of the diagnostic process; multiplying yield per cost according to the three scenarios describing the new WHO strategy and a fourth scenario describing the old strategy. In the Ivanovo Oblast the cost per case cured, at 85% cure rate level, ranged from US$ 1197 (new strategy, scenario 1 without food) to US$ 6293 (old strategy, scenario 4) the cost per case detected ranged from US$ 1581 (new strategy, scenario 1) to US$ 4000 (old strategy, scenario 4). Significant savings can result from shifting towards the new WHO strategy. Decision-makers and health administrators should be responsible for re-investing the financial and human resources mobilized by the adoption of cost-effective strategies within the TB control programme.

摘要

俄罗斯联邦目前的许多结核病控制项目都基于成本高昂的策略,这些策略资金不足,且采用长期、个体化的治疗方案。本文采用成本效益分析方法,比较了在伊万诺沃州实施的世卫组织新策略(对有症状患者进行病例发现(SCF)和采用较短治疗方案)和旧策略(对无症状人群进行主动筛查(ACF)和采用较长治疗方案)。使用三种情景来描述世卫组织新策略(采用世卫组织推荐的治疗方案以及三种不同入院率的选择)和一种情景来描述旧策略(所有患者接受全程治疗且采用较长治疗方案),计算了在不同治愈率水平(45%-95%)下每治愈一例的成本。通过计算以下内容确定每例检测成本:新旧策略的检出率(诊断一例所需的检查次数);诊断过程的成本;根据描述世卫组织新策略的三种情景和描述旧策略的一种情景,将检出率乘以成本。在伊万诺沃州,治愈率为85%时,每治愈一例的成本从1197美元(新策略,情景1,无食物)到6293美元(旧策略,情景4)不等,每例检测成本从1581美元(新策略,情景1)到4000美元(旧策略,情景4)不等。转向世卫组织新策略可带来显著节省。决策者和卫生管理人员应负责将通过采用具有成本效益的策略在结核病控制项目中筹集的资金和人力资源进行再投资。

相似文献

1
Cost-effectiveness analysis of tuberculosis control policies in Ivanovo Oblast, Russian Federation. Ivanovo Tuberculosis Project Study Group.俄罗斯联邦伊万诺沃州结核病控制政策的成本效益分析。伊万诺沃结核病项目研究小组
Bull World Health Organ. 1998;76(5):475-83.
2
Cost-comparison of different management policies for tuberculosis patients in Italy. AIPO TB Study Group.意大利不同结核病患者管理政策的成本比较。意大利肿瘤患者协会结核病研究组
Bull World Health Organ. 1999;77(6):467-76.
3
DOTS in Cambodia. Directly observed treatment with short-course chemotherapy.柬埔寨的直接督导下短程化疗。
Int J Tuberc Lung Dis. 1998 Jan;2(1):44-51.
4
Cost-effectiveness analysis of an alternative tuberculosis management strategy for permanent farm dwellers in South Africa amidst health service contraction.南非永久性农场居民在卫生服务缩减背景下的替代性结核病管理策略成本效益分析
Scand J Public Health. 2006;34(1):83-91. doi: 10.1080/14034940510032220.
5
Cost-effectiveness analysis of the russian treatment scheme for tuberculosis versus short-course chemotherapy: results from Tomsk, Siberia.俄罗斯结核病治疗方案与短程化疗的成本效益分析:来自西伯利亚托木斯克的结果。
Int J Tuberc Lung Dis. 2002 May;6(5):396-405.
6
Cost-effectiveness of different treatment strategies for tuberculosis in Egypt and Syria.埃及和叙利亚不同结核病治疗策略的成本效益
Int J Tuberc Lung Dis. 2002 Dec;6(12):1083-90.
7
Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi.马拉维利隆圭区加强社区和初级保健机构参与结核病防治工作的成本及成本效益
Int J Tuberc Lung Dis. 2003 Sep;7(9 Suppl 1):S29-37.
8
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
9
[Cost benefit of detection and treatment patients with tuberculosis in Ivanovo region, Russian Federation].[俄罗斯联邦伊万诺沃地区结核病患者检测与治疗的成本效益]
Probl Tuberk. 1998(3):9-13.
10
Primary multidrug-resistant tuberculosis--Ivanovo Oblast, Russia, 1999.原发性耐多药结核病——俄罗斯伊万诺沃州,1999年
MMWR Morb Mortal Wkly Rep. 1999 Aug 6;48(30):661-4.

引用本文的文献

1
Population-based active screening strategy contributes to the prevention and control of tuberculosis.基于人群的主动筛查策略有助于结核病的预防和控制。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Dec 25;51(6):669-678. doi: 10.3724/zdxbyxb-2022-0426.
2
Tuberculosis active case finding in Cambodia: a pragmatic, cost-effectiveness comparison of three implementation models.柬埔寨结核病活动性病例发现:三种实施模式的务实成本效益比较
BMC Infect Dis. 2017 Aug 22;17(1):580. doi: 10.1186/s12879-017-2670-8.
3
Drug-resistant tuberculosis in Eastern Europe: challenges and ways forward.东欧的耐药结核病:挑战与未来之路
Public Health Action. 2014 Oct 21;4(Suppl 2):S3-S12. doi: 10.5588/pha.14.0087.
4
Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.结核病治疗对医疗服务机构和患者的成本:一项系统文献综述
Pharmacoeconomics. 2015 Sep;33(9):939-55. doi: 10.1007/s40273-015-0279-6.
5
The Effectiveness of Family-Based DOTS versus Professional-Family Mix DOTS in Treating Smears Positive Tuberculosis.基于家庭的直接观察短程疗法与专业-家庭混合直接观察短程疗法治疗涂片阳性结核病的疗效比较
Health Promot Perspect. 2014 Jul 12;4(1):98-106. doi: 10.5681/hpp.2014.013. eCollection 2014.

本文引用的文献

1
Tuberculosis in Siberia: 1. An epidemiological and microbiological assessment.西伯利亚的结核病:1. 流行病学与微生物学评估。
Tuber Lung Dis. 1996 Jun;77(3):199-206. doi: 10.1016/s0962-8479(96)90001-5.
2
Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic.全球结核病流行病学。一场全球流行病的发病率和死亡率。
JAMA. 1995 Jan 18;273(3):220-6.
3
Tuberculosis trends in eastern Europe and the former USSR.东欧及前苏联地区的结核病趋势
Tuber Lung Dis. 1994 Dec;75(6):400-16. doi: 10.1016/0962-8479(94)90113-9.
4
The supply of antituberculosis drugs: price evolution.抗结核药物的供应:价格演变
Tuber Lung Dis. 1995 Jun;76(3):261-3. doi: 10.1016/s0962-8479(05)80015-2.
5
Tuberculosis elimination in the countries of Europe and other industrialized countries.欧洲国家及其他工业化国家的结核病消除工作。
Eur Respir J. 1991 Nov;4(10):1288-95.